-
Mashup Score: 0
William Blair analyst Margaret Kaczor reported surprise at the increase in users of CGM within the non-insulin and basal insulin populations.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Biolinq raises $58M to support intradermal glucose sensor - 26 day(s) ago
Biolinq announced today that it completed a $58 million financing to support the progression of its proprietary intradermal glucose sensor.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0FDA clears Baxter Novum IQ infusion pump, Dose IQ software - 29 day(s) ago
Baxter announced today that the FDA granted 510(k) clearance for its Novum IQ large-volume infusion pump (LVP) with Dose IQ safety software.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Tandem taps miniaturization, automation in its latest systems - 1 month(s) ago
Tandem Diabetes Care (Nasdaq:TNDM) EVP and Chief Strategy Officer, Elizabeth Gasser, didn’t exactly plan for the whirlwind past year or so.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0FDA submission for 365-day CGM from Senseonics is 'imminent' - 2 month(s) ago
Senseonics (NYSE:SENS) shares dipped after hours on fourth-quarter results that came in ahead of the consensus forecast.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0These diabetes devices are set to launch in 2024 - 2 month(s) ago
The diabetes space continues to innovate and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Senseonics earns expanded Medicare coverage for CGM implant - 3 month(s) ago
Senseonics and Ascensia Diabetes Care today announced expanded Medicare coverage for the Eversense E3 CGM system.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Fractyl Health goes the IPO route - 3 month(s) ago
Fractyl Health — developer of medtech and gene therapies to reverse diabetes and obesity — began trading on the Nasdaq today.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Samsung could battle Apple over non-invasive glucose monitors - 3 month(s) ago
Bloomberg reports that Samsung has eyes on developing non-invasive glucose monitoring technology, potentially pitting it against Apple.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Glucotrack has positive data for implantable blood glucose monitor - 4 month(s) ago
Glucotrack announced today that it completed the first preclinical study of its implantable continuous blood glucose monitor (CBGM).
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
Non-insulin, basal #CGM use exceeds analysts’ expectations, @Dexcom and Abbott @FreeStyleLibre to benefit - nearly 300,000 new non-insulin CGM users, compared to a projection of 200,000 | #diabetes https://t.co/s93hRbNsoo